Circulating monocyte chemoattractant protein-1 and early development of nephropathy in type 1 diabetes |
| |
Authors: | Chiarelli Francesco Cipollone Francesco Mohn Angelika Marini Matteo Iezzi Annalisa Fazia Maria Tumini Stefano De Cesare Domenico Pomilio Mariapina Pierdomenico Sante D Di Gioacchino Mario Cuccurullo Franco Mezzetti Andrea |
| |
Institution: | Clinica Pediatrica, University of Chieti, Chieti, Italy. Patologia Medica, University of Chieti, Chieti, Italy. chiarelli@unich.it |
| |
Abstract: | OBJECTIVES: To investigate the possible role of hyperglycemia-dependent monocyte chemoattractant protein (MCP)-1 biosynthesis in the pathophysiology of early nephropathy in type 1 diabetes. RESEARCH DESIGN AND METHODS: We studied 30 patients with type 1 diabetes (15 with and 15 without microalbuminuria) compared with matched healthy control subjects. Plasma MCP-1 and plasma oxidant status (vitamin E, fluorescent products of lipid peroxidation FPLPs], malondialdehyde MDA]), HbA(1c), and albumin excretion rate AER]) were evaluated at baseline. Furthermore, MCP-1, vitamin E, AER, and HbA(1c) were also analyzed in the microalbuminuric diabetic patients and in the healthy volunteers after 8 weeks of high-dose (600 mg b.i.d.) vitamin E treatment. RESULTS: FPLPs, MDA, and MCP-1 were significantly higher, whereas vitamin E was significantly lower in patients with microalbuminuria and poorer glycemic control as compared with normoalbuminuric patients and healthy control subjects. Plasma MCP-1 was positively correlated with HbA(1c), FPLPs, MDA, and AER, whereas plasma MCP-1 showed an inverse correlation with vitamin E. Interestingly, both MCP-1 and AER decreased significantly after vitamin E treatment, despite no changes in HbA(1c) values. CONCLUSIONS: This study suggests that prolonged hyperglycemia may lead to early renal complications in type 1 diabetes by inducing MCP-1 biosynthesis via enhanced oxidative stress. Long-term treatment of high-dose vitamin E significantly decreased MCP-1, thus providing a rationale basis for evaluating vitamin E supplementation as therapy adjuvant to conventional insulin treatment in type 1 diabetic patients in whom an acceptable glycemic control is difficult to achieve despite appropriate insulin treatment. |
| |
Keywords: | |
本文献已被 PubMed 等数据库收录! |
|